Literature DB >> 32102282

The Administration of 4-Hexylresorcinol Accelerates Orthodontic Tooth Movement and Increases the Expression Level of Bone Turnover Markers in Ovariectomized Rats.

Kwang-Hyo Choi1, Dae-Won Kim2, Suk Keun Lee3, Seong-Gon Kim4, Tae-Woo Kim1.   

Abstract

Surgical methods for accelerating orthodontic tooth movement are limited by possible damage to the tooth root and patient discomfort. 4-Hexylresorcinol (4HR) has been shown to increase bone remodeling and may potentially facilitate tooth movement. This study investigated the (1) effect of 4HR administration on osteoblast-like cells and (2) effect of 4HR administration on tooth movement in ovariectomized rats. Saos-2 cells were treated with either 4HR or solvent (control). Protein expression levels were investigated 2, 8, and 24 h after treatment. Thirty ovariectomized Sprague-Dawley rats were divided into two experimental groups (A and B) and one control group. After installation of an orthodontic tooth movement device, groups A and B received subcutaneous weekly injections of 4HR (1.28 and 128 mg/kg). Micro-computerized tomography and histological analyses were performed after 2 weeks of tooth movement. The application of 4HR elevated expression of osteogenic markers in Saos-2 cells. Movement of the first molars was significantly greater in rats administered 4HR. Furthermore, the expression of bone morphogenic protein-2, receptor activator of nuclear factor kappa-B ligand, osteocalcin, and tartrate-resistant acid phosphatase were increased after 4HR administration. 4HR application demonstrated increased expression of osteogenic markers in Saos-2 cells and accelerated orthodontic tooth movement in rats.

Entities:  

Keywords:  4-hexylresorcinol; animal model; bone morphogenic protein; nuclear factor kappa-B ligand; orthodontic; ovariectomy; tooth movement

Year:  2020        PMID: 32102282     DOI: 10.3390/ijms21041526

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  6 in total

1.  Effects of 4-hexylresorcinol administration on the submandibular glands in a growing rat model.

Authors:  Joo-Hyung Yoon; Dae-Won Kim; Suk Keun Lee; Seong-Gon Kim
Journal:  Head Face Med       Date:  2022-06-06       Impact factor: 2.246

2.  Alveolar bone response distal to applied orthodontic forces in ovariectomized rats.

Authors:  Apostolos I Tsolakis; Lubna Khaldi; Aliki Rontogianni; Maria Georgaki; Isidora Christopoulou; Ismene A Dontas
Journal:  J Musculoskelet Neuronal Interact       Date:  2022-06-01       Impact factor: 1.864

3.  4-Hexylresorcinol-in duced angiogenesis potential in human endothelial cells.

Authors:  Min-Keun Kim; Seong-Gon Kim; Suk Keun Lee
Journal:  Maxillofac Plast Reconstr Surg       Date:  2020-06-29

4.  Increased Level of Vascular Endothelial Growth Factors by 4-hexylresorcinol is Mediated by Transforming Growth Factor-β1 and Accelerates Capillary Regeneration in the Burns in Diabetic Animals.

Authors:  Dae-Won Kim; You-Young Jo; Umberto Garagiola; Je-Yong Choi; Yei-Jin Kang; Ji-Hyeon Oh; Seong-Gon Kim
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

5.  4-Hexylresorcinol inhibits osteoclastogenesis by suppressing the NF-κB signaling pathway and reverses bone loss in ovariectomized mice.

Authors:  Wenkai Yi; Tao Liu; Xinfeng Gao; Yonghua Xie; Ming Liu
Journal:  Exp Ther Med       Date:  2021-02-11       Impact factor: 2.447

Review 6.  4-Hexylresorcinol: pharmacologic chaperone and its application for wound healing.

Authors:  Seong-Gon Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2022-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.